Journal of Cardiology and Therapy
http://ghrnet.org/index.php/jct
ISSN-Online: 2312-122X<br />Frequency: Biannually, Instant published<br />Journal Access: Open Access<br /> The first Issue: June, 2013<br /><br />en-USJournal of Cardiology and Therapy2309-6861<p>Submission of a manuscript implies that the work described is not simultaneously being considered by other journals or is already published elsewhere; That the material contained within the manuscript is original, with all information from other sources appropriately referenced, and that written specific permission has been granted by any existing copyright holders prior to publication and is clearly cited and available. That its publication has been approved by all co-authors; That the author(s) agree to transfer to ACT Publishing Group Inc exclusive copyright ownership for all formats of the manuscript, including print and electronic formats, English and non-English language formats, and subsequent editions; That the author(s) acknowledge that all articles published by ACT Publishing Group Inc are selected by an in-house editor and fully peer-reviewed by external reviewers. ACT Publishing Group Inc applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <a href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</a>. The corresponding author and all co-authors, signs a copyright transfer form at the time of submission of the manuscript; That all figures and tables have been correctly placed and clearly identified, and meet the journal’s standards of high-resolution quality. The Journal or the publisher will not be held legally responsible should there be any claims for compensation.</p>Publicizing the Cardiovascular Health Benefits of Donating Blood Could Help Alleviate the Blood Shortage
http://ghrnet.org/index.php/jct/article/view/3383
A shortage in the supply of blood products developed in the United States following the coronavirus disease 2019 pandemic, but shortages have always affected some lower and middle-income countries. Donating blood reduces blood viscosity by lowering the hematocrit in the short term and promoting the replacement of older, stiffer erythrocytes with fresh, maximally deformable ones over the long term. It also reduces plasma viscosity. By lowering blood viscosity, blood donation protects against atherosclerotic cardiovascular disease and treats metabolic syndrome. Promoting the benefits of blood donation to the donor may help alleviate blood shortages.Gregory D. SloopGheorghe A. PopJoseph J. WeidmanJohn A. St. Cyr2023-06-302023-06-3010